☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Teva
Insights+ Key Biosimilars Events of May 2024
June 4, 2024
Teva and Alvotech Launches Simlandi (Biosimilar, Humira) Injection Across US to Treat Multiple Indications
May 20, 2024
Teva and Alvotech’s Selarsdi (Biosimilar, Stelara) Receives the US FDA’s Approval
April 17, 2024
Teva Presents P-IV (UNITE) Study Results of Ajovy (fremanezumab) for Migraine and Major Depressive Disorder at World Congress of N...
October 17, 2023
Insights+: The US FDA New Drug Approvals in May 2023
June 22, 2023
Teva and MedinCell Receive the US FDA’s Approval of Uzedy (risperidone) Extended-Release Injectable Suspension for Schizophrenia
May 1, 2023
Load more...
Back to Home